Nortriptyline Use in Dialysis Patients

Safety Considerations

• The Kidney International guidelines recommend exercising caution with all psychotropic medications in dialysis patients due to potential for QT prolongation and altered pharmacodynamics in the setting of kidney failure 1
• The Kidney International guidelines suggest applying principles of psychotropic prescribing in medically fragile patients: uptitrate from subtherapeutic doses carefully, prioritizing both efficacy and safety 1

Context: Depression Management in Dialysis

• The Kidney International guidelines state that SSRIs have not shown consistent benefit over placebo in small randomized trials of hemodialysis patients and are associated with increased adverse effects, particularly gastrointestinal 1
• The Kidney International guidelines note that no randomized controlled trials address SSRI use in peritoneal dialysis patients 1, 2
• Cognitive behavioral therapy should be initiated alongside any pharmacologic management, as psychological interventions have demonstrated efficacy in reducing depression in dialysis patients, according to the Kidney International guidelines 1
• Aerobic exercise shows moderate-quality evidence for decreasing depressive symptoms and should be encouraged according to patient ability, as recommended by the Kidney International guidelines 1, 2

Critical Pitfalls to Avoid

• The Praxis Medical Insights guidelines recommend avoiding concurrent NSAIDs entirely, as they accelerate loss of residual kidney function 4
• The Praxis Medical Insights guidelines suggest monitoring for additive CNS depression if patients are on multiple sedating medications (opioids, benzodiazepines) 4